Foster common approaches between People’s Republic of China and the European Union on Personalised Medicine research, development, innovation and policies
News
A short and comprehensive guide for Personalised Medicine strategies and programmes in China
Personalised Medicine in the People’s Republic of China is principally developed through the Five-Year Plans, that include [...]
Sino-European Health Collaboration Week: Find the presentations here!
Did you enjoy the Sino-European Health Collaboration Week ? Find here the material presented during the event! By [...]
IC2PerMed’s 1st deliverable published on the website!
We are happy to announce that our “Scoping Paper: Review on health research and innovation priorities in [...]
IC2PerMed at a glance
Supporting International collaboration for the development of Personalised Medicine
The International Consortium for Personalised Medicine (ICPerMed), umbrella initiative of IC2PerMed, aims at initiating and supporting communication and exchange on Personalised Medicine (PM) for aligning national agendas on research and funding activities. It brings together representatives of funding agencies and authorities from 29 countries and expands for increasing PM developments’ synergies at international level.
IC2PerMed project’s core objective is to build upon collaborative developments of Chinese and European experts on PM for elaborating a common strategy, enabling Chinese institutions to join the ICPerMed consortium. The 3 Expert Working Groups will set the path for a common approach of PM research, innovation, development and implementation over the project duration.
